NCT00459069View on ClinicalTrials.gov

The Use of Dendritic Cell/Tumor Fusions as a Novel Tumor Vaccine in Patients With Multiple Myeloma

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

June 30, 2008

Study Completion Date

November 30, 2009

Conditions
Multiple Myeloma
Interventions
BIOLOGICAL

Dendritic Cell Tumor Fusion Vaccine

Vaccine administered on weeks 0, 3 and 6

Trial Locations (1)

02114

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

Dana-Farber Cancer Institute

OTHER

collaborator

Brigham and Women's Hospital

OTHER

lead

Beth Israel Deaconess Medical Center

OTHER

NCT00459069 - The Use of Dendritic Cell/Tumor Fusions as a Novel Tumor Vaccine in Patients With Multiple Myeloma | Biotech Hunter | Biotech Hunter